• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿中C1酯酶抑制剂的分子表达。对32个家族的研究(作者译)

[The molecular expression of C1 esterase inhibitor in hereditary angioneurotic oedema. Study of 32 families (author's transl)].

作者信息

Ollier M P, Hartmann L, Brecy H

出版信息

Nouv Presse Med. 1978 Sep 30;7(33):2933-8.

PMID:724440
Abstract

Seventy seven patients from 32 families suffereing from angioneurotic oedema were studied and a single theory of the disorder is suggested. The functional abnormality of alpha2 neuraminoglycoprotein (NGP) or of C1 esterase inhibitor is related involvement of the structure gene (s) controlling its synthesis. Particular immunochemical characteristics of the inhibitor seen in severals families and remaining constant through a number of generations would indicate the existence of a phenomenon of functional haploidism in these heterozygous patients. Treatment of the condition with androgens suggests the existence of two varieties of alpha2 NGP molecules which are differentiated on the basis of their complete or incomplete glycoconjugation in the hepatocyte.

摘要

对来自32个患有血管性水肿家庭的77名患者进行了研究,并提出了关于该疾病的单一理论。α2神经氨酸糖蛋白(NGP)或C1酯酶抑制剂的功能异常与控制其合成的结构基因的相关参与有关。在几个家族中观察到的抑制剂的特定免疫化学特征,并在几代人中保持不变,这表明这些杂合子患者中存在功能单倍体现象。用雄激素治疗该疾病表明存在两种α2 NGP分子,它们根据在肝细胞中的完全或不完全糖缀合而有所区别。

相似文献

1
[The molecular expression of C1 esterase inhibitor in hereditary angioneurotic oedema. Study of 32 families (author's transl)].遗传性血管性水肿中C1酯酶抑制剂的分子表达。对32个家族的研究(作者译)
Nouv Presse Med. 1978 Sep 30;7(33):2933-8.
2
The gene(s) controlling the synthesis of C1 esterase inhibitor is not linked to the genes of the HLA system and is not on the 6th chromosome.控制C1酯酶抑制剂合成的基因与HLA系统的基因不连锁,且不在第6号染色体上。
Biomedicine. 1978 Nov;29(7):248-52.
3
Familial occurrence of C1-inhibitor deficiency and the effect of treatment.C1抑制物缺乏症的家族性发病情况及治疗效果。
Arch Immunol Ther Exp (Warsz). 1989;37(5-6):669-74.
4
[Hereditary angioneurotic edema. Clinical aspects, pathogenesis and therapy].[遗传性血管性水肿。临床特点、发病机制与治疗]
Helv Paediatr Acta. 1978 Aug;33(3):259-66.
5
[Study by means of enzymatic and immunochemical determination of Cl esterase inhibitor in 59 patients with hereditary angioneurotic edema].[采用酶法和免疫化学法对59例遗传性血管性水肿患者的Cl酯酶抑制剂进行研究]
Boll Ist Sieroter Milan. 1977 Mar 31;56(1):22-8.
6
Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema.一种新型雌激素 dependent 遗传性血管性水肿的临床、生化和遗传学特征
J Allergy Clin Immunol. 2000 Sep;106(3):546-50. doi: 10.1067/mai.2000.108106.
7
Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.C1抑制物正常的遗传性血管性水肿:临床症状与病程
Am J Med. 2007 Nov;120(11):987-92. doi: 10.1016/j.amjmed.2007.08.021.
8
[Abdominal manifestations in hereditary acute angioneurotic oedema. Value of study of the complement system (author's transl)].[遗传性急性血管神经性水肿的腹部表现。补体系统研究的价值(作者译)]
Nouv Presse Med. 1977 Jun 18;6(25):2233, 2235-8.
9
[Abdominal manifestations of hereditary angioneurotic edema. Importance of the exploration of the complement system (apropos of 29 families)].[遗传性血管性水肿的腹部表现。补体系统检测的重要性(关于29个家庭)]
Biomedicine. 1976 Dec 15;24(6):443-9.
10
Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema.匈牙利遗传性血管性水肿患者中C1抑制剂基因的突变筛查
Hum Mutat. 2003 Dec;22(6):498. doi: 10.1002/humu.9202.